Combinations of on-patent therapies (CTs) are increasingly common in oncology. They cause challenges for funding and affordability, and hence patient access, especially when constituent therapies are owned by different manufacturers. The aim of our study was to develop policy proposals for the assessment, pricing, and funding of CTs and identify which might be relevant in different European countries. Lien vers l'article
HENSHALL, C.H., DANKÓ, D., BARHAM, L., ESPÍN, J., FELIX, J., HARNEY, M. ... WILKING, N. (2023). Review and Assessment of Policy Options for Improving Access to Combination Therapies in Oncology in Europe. Applied Health Economics and Policy, In press.